MS – Y6.NO

Hjernens helse p? dagsorden

10 mars 201415 desember 2019 y6.no

Ny MS-pille godkjent til norske pasienter

3 mars 201415 desember 2019 y6.no

TECFIDERA? (DIMETHYL FUMARATE) APPROVED IN THE EUROPEAN UNION AS A FIRST-LINE ORAL TREATMENT FOR MULTIPLE SCLEROSIS

3 februar 201415 desember 2019 y6.no

NEW DATA ANALYSES SHOW SIGNIFICANT CLINICAL AND MRI IMPROVEMENTS WITH PLEGRIDY (PEGINTERFERON BETA-1A)

9 oktober 201315 desember 2019 y6.no

NEW TYSABRI? DATA SHOW EARLIER TREATMENT AND LONGER-TERM USE RESULT IN SIGNIFICANT REDUCTIONS IN MS DISEASE ACTIVITY

9 oktober 201315 desember 2019 y6.no

BIOGEN IDEC?S TECFIDERA? (DIMETHYL FUMARATE) APPROVED IN US AS A FIRST-LINE ORAL TREATMENT FOR MULTIPLE SCLEROSIS

3 april 201315 desember 2019 y6.no